Navigation Links
Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)
Date:3/7/2008

ier, Vice-President EURMEAAS (Europe, Middle-East, Africa, Australia and Asia).

The corrective and aesthetic procedures market has more than doubled in the last five years with doctors using topical anesthetics for one in four of those procedures.

Galderma launched Pliaglis(TM) earlier this year in the USA and expects to file it with the regulatory authorities in the main worldwide markets later in 2008.

This license follows several recent transactions aimed at enriching Galderma's product offering to dermatology patients.

About Galderma:

Galderma, created in 1981 as a joint venture between Nestle and L'Oreal, is a fully integrated specialty pharmaceutical company dedicated exclusively to dermatology. The Company has a presence in 65 countries with over 1000 sales representatives and is committed to improving the health of skin with an extensive line of products that treat a range of dermatological conditions including: acne, rosacea, fungal nail infections, psoriasis & steroid-responsive dermatoses, pigmentary disorders, skin cancers and medical solutions for skin senescence.

Galderma's new centre in Sophia Antipolis, France is the largest facility in the world dedicated to Research and Development in dermatology.

Galderma leading brands include Differin(R), Rozex(R)/Metro(R), Clobex(R), Tri-Luma(R), Loceryl(R) and Cetaphil(R). Recently launched products include Pliaglis(TM), a topical anaesthetic for dermatologic procedures in the United States, Epiduo(R), an innovative combination product for the treatment of acne in Europe and Argentina and Dysport(R), an injectable neuro-modulator for the correction of wrinkles in Brazil and Argentina. The Company's website is http://www.galderma.com.

About ZARS Pharma:

ZARS Pharma is a specialty pharmaceutical company focused on the development and commercialization of topically administered drugs using proprietar
'/>"/>

SOURCE Galderma Pharma, S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
2. Galderma Associates Itself to Cartiers Womens Initiative Awards to Recognize Female Entrepreneurs From Around the Globe
3. Legislative and Regulatory Outlook - 2009 and Beyond for Pharma, Biotech Players
4. TyRx Pharma, Inc. Announces Presentation of Results to Benefit Women with Breast Implants (In-Vivo Efficacy Study Regarding AIGISRx DEB) at the Plastic Surgery 2007 Meeting on October, 28 2007 in Baltimore, MD
5. GeoPharma, Inc. to Present at the EdgeWater Research Investor Conference
6. FDA Extends Review Timeline for Additional Indication for Antibiotic DORIBAX(TM)
7. Perrigo Company to Market Over-the-Counter Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride Extended-Release Tablets
8. Conseco Files to Formally Extend Due Date for Annual Report on Form 10-K to March 17 and Reschedules Earnings Release and Investor Call
9. FDA Approves Luvox(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
10. Actavis Extends Portfolio With Four New Products in the U.S.
11. CDC Panel Urges Extending Flu Vaccine Coverage for Kids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... September 02, 2015 , ... Ericson is a noted speaker ... for HCPro and Associate Director of Education for the Association for Clinical Documentation Improvement ... ICD-10 for CDI Boot Camps. She serves as a CDI subject matter expert for ...
(Date:9/2/2015)... Appleton, WI (PRWEB) , ... September 02, 2015 ... ... Midwest, Cypress Benefit Administrators is taking action after seeing a significant ... The TPA’s Argus Claim Review division has found many cases of OON ASCs ...
(Date:9/2/2015)... ... 2015 , ... The 2015 China Overseas Investment and Entrepreneurship ... conference will be hosted at five star Beijing Kunlun Hotel and Diaoyutai State ... feature leading EB-5 industry professionals and Chinese private equity partners looking for international ...
(Date:9/2/2015)... ... 02, 2015 , ... Amada Senior Care, premier provider of in-home care and ... Johnson County location. Amada franchise partners Mike and Mell Fleming came to the ... spent over 20 years in medical device sales while Mell spent over 30 years ...
(Date:9/2/2015)... ... September 02, 2015 , ... SonicSurg Innovations, ... market, announced today that more than 600 successful patient procedures have been performed ... Plus, nearly 70 of these procedures have been on triggering thumbs. , ...
Breaking Medicine News(10 mins):Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 3Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 4Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 3Health News:The 2015 China Overseas Investment and Entrepreneurship Summit (COIES) Announced 2Health News:Amada Senior Care Expands to Greater Kansas City 2Health News:Trigger Tome Surpasses 600 Successful Patient Procedures 2
... in lab tests, researchers say , FRIDAY, Feb. 26 ... after diagnosis, but researchers have identified an oncogene that ... Even more hopeful is that drugs that target this ... are undergoing tests with colon and lung cancers, said ...
... for autism, stroke and other conditions , FRIDAY, ... of children,s brains during reading discovered something rather unexpected: ... of white matter tracts in the brain, and the ... out words. , "This is the first evidence ...
... account, researcher says , FRIDAY, Feb. 26 (HealthDay News) ... for pregnant women and their unborn babies mean that ... diagnosed with gestational diabetes, a new study suggests. , ... women being diagnosed with gestational diabetes, the new measurements ...
... ... ... ... ...
... ... ... , , , ... ...
... , ... ... ... ...
Cached Medicine News:Health News:New Treatment Eyed for Deadly Pancreatic Cancer 2Health News:New Treatment Eyed for Deadly Pancreatic Cancer 3Health News:Reading Remediation Seems to Rewire the Brain 2Health News:Reading Remediation Seems to Rewire the Brain 3Health News:Twice as Many Women May Soon Be Diagnosed With Gestational Diabetes 2Health News:Pelosi, Obama Mislead on Abortion Funding in Health Care Bill 2Health News:Pelosi, Obama Mislead on Abortion Funding in Health Care Bill 3Health News:Pelosi, Obama Mislead on Abortion Funding in Health Care Bill 4Health News:Brain Cancer Survivor Will Cycle 4,170 Miles Across USA to 'Outsmart' Disease 2Health News:Brain Cancer Survivor Will Cycle 4,170 Miles Across USA to 'Outsmart' Disease 3Health News:Brain Cancer Survivor Will Cycle 4,170 Miles Across USA to 'Outsmart' Disease 4Health News:New Building at University of Michigan Health System Expands Eye Care, Unites Diabetes Researchers 2Health News:New Building at University of Michigan Health System Expands Eye Care, Unites Diabetes Researchers 3Health News:New Building at University of Michigan Health System Expands Eye Care, Unites Diabetes Researchers 4Health News:New Building at University of Michigan Health System Expands Eye Care, Unites Diabetes Researchers 5Health News:New Building at University of Michigan Health System Expands Eye Care, Unites Diabetes Researchers 6Health News:New Building at University of Michigan Health System Expands Eye Care, Unites Diabetes Researchers 7Health News:New Building at University of Michigan Health System Expands Eye Care, Unites Diabetes Researchers 8
(Date:9/2/2015)... NEW YORK , Sept. 2, 2015 ... developing novel therapies for the treatment of chronic pain, ... investor meetings at both the FBR Second Annual Healthcare ... are as follows: FBR Second Annual Healthcare ... Seasons, Boston No presentation, ...
(Date:9/2/2015)... VANCOUVER, British Columbia and ...   DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ... on the development and commercialization of new cancer ... abstract entitled, "A Comparison of the Mechanisms ... in Ovarian Tumor Models Harboring Wild-type and Mutant ...
(Date:9/2/2015)... 2, 2015 Ascletis announced today the completion ... investment was led by C-Bridge Capital, joined by Tasly ... The valuation of the Company before financing was US$300 ... be used to expand Ascletis, pipeline, strengthen global development ... the support of the investors, Ascletis is now entering ...
Breaking Medicine Technology:Relmada Therapeutics to Participate in Two Upcoming Investor Conferences 2DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 2DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 3DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 4Ascletis Secures US$35 Million Financing 2Ascletis Secures US$35 Million Financing 3
... Osteopal V is a low viscosity bone ... in vertebroplasty. The bone cement is injected ... purposes. Osteopal V is used for the ... of zirconium dioxide is included in the ...
Based on the trusted Schaltenbrand-Wahren Atlas for Stereotaxy of the human brain, Atlasplan Software provides anatomical detail of the basal ganglia region of the brain and can help confirm target a...
... a comprehensive platform for standard neurosurgical ... to plan the optimal surgical path ... Combined with unique features such as ... planning tool, Neurosight becomes a very ...
3D Cranial is the most widely used surgical navigation software. Navigate with confidence and ease with our displayed Zone of Accuracy and several fully automated features. 3D Cranial offers seamless...
Medicine Products: